Clinical trial · Interventional
Comparative Study of 22 and 25 Gauge ProCore EUS-guided Biopsy in Pancreatic Mass
Endoscopic Ultrasound-guided Fine Needle Tissue Acquisition With 22- and 25-gauge ProCore Needle in Solid Pancreatic and Peripancreatic Masses: A Prospective Comparative Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Background: EUS-guided fine needle aspiration (FNA) is a major diagnostic tool in the patient with pancreatic mass with high specificity, specificity and accuracy. However FNA with small needle has sometimes failed in acquisition of tissue due to small caliber. To overcome this limitation, newly designed ProCore needle was developed and flexible 22 and 25 gauge ProCore needles were frequently used. However there was no comparative study of the efficacy and accuracy between 22 and 25 gauge ProCore needle yet. Aim: To compare the efficacy and accuracy of EUS-guided FNA between 22 and 25 gauge ProCore needle. (The investigators hypothesized that the accuracy of 25 gauge Procore needle is not inferior to 22 gauge ProCore needle.)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Neoplasms | Pancreatic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 22 gauge ProCore needle biopsy | Device | — | UNRESOLVED |
| 25 gauge ProCore needle biopsy | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- 22 gauge ProCore needle biopsy
- description
- EUS-guided pancreatic or peripancreatic mass biopsy with 22 gauge ProCore biopsy needle.
- interventionNames
- Device: 22 gauge ProCore needle biopsy
- type
- ACTIVE_COMPARATOR
- label
- 25 gauge ProCore needle biopsy
- description
- EUS-guided pancreatic or peripancreatic mass biopsy with 25 gauge ProCore biopsy needle.
- interventionNames
- Device: 25 gauge ProCore needle biopsy
Primary outcomes (1)
- measure
- Diagnostic accuracy
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who agree to participate in research * 18 years of age and older patients * Patients who have pancreatic or peripancreatic mass in imaging studies Exclusion Criteria: * Contraindication to endoscopy * Patients younger than 18 years old * Bleeding tendency * Cardiopulmonary dysfunction
References
Publications (0)
Data not yet available